2016年6月2日

2016年6月1日Medella健康,分享公司的创始团队包括泰尔研究员和赛车谷歌和诺华发展glucose-sensing隐形眼镜,已经筹集了140万美元资金。没有太多的已知Medella的镜头。该公司表示,它将把一个小传感器芯片,和micro-antenna葡萄糖读数传送给移动设备,并在接近实时用户跟踪他们的葡萄糖。他们最大的创新是一个传感器声称,将持续一个月,创始人兼首席执行官哈里·甘地说给他们胜过生命科学(原谷歌),实在为诺华制药正在开发一个类似的技术。“至于实在和团队所做的工作,他们之前在微电子技术和领先的传感技术,“甘地在一封电子邮件中告诉MobiHealthNews。“我们的传感器能够持续30天(而不是几天),显著延长隐形眼镜的生命周期,从而使校准更简单得多用户和降低成本的血糖监测。“甘地说,该公司将使用种子资金规模的技术和寻找合作伙伴生产和销售该产品的其他方面,包括micro-fabrication公司、隐形眼镜制造商和卫生保健提供者。“我们有一个令人兴奋的未来一年的我们,”他在一份声明中说。“我们已经召集了一些最聪明的人们工作的问题是根深蒂固的在我们的医疗保健系统。从未有一个更好的时间来做这个,我们的医疗保健系统中断的时机已经成熟,行业领袖和关键意见领袖倡导从被动转向医疗保健预防模式的典范。“从理论上讲,隐形眼镜可以检测一个人的血糖水平基于他们的眼泪。 But when MobiHealthNews interviewed several industry experts in 2014 -- after Google announced its project -- they all expressed various levels of skepticism that reliable glucose monitoring via a contact lens could be done. But now the question seems to be not "Can it be done? " but "Who will do it first? " Even with Peter Thiel's vote of confidence, Medella seems like something of an underdog. The company has been working on this for three years, and Gandhi is still confident in their efforts. "We’re extremely proud of how we’ve brought the team together and all the work we’ve done since we first started in early 2013," he said in a statement. "The months ahead are going to be an extremely exciting time for us, as we will be perfecting the technology we’ve built and working with the regulatory bodies to get approval.” Tags: